Ebola | |||||
NEWS | |||||
Regeneron lands BARDA contract for Ebola cocktail ... (NASDAQ:REGN) for a supply of REGN-EB3, its cocktail of three fully-human monoclonal antibodies for the treatment of Ebola virus infection, for the ...
| |||||
WEB | |||||
How Ebola Lingers Long-Term Many studies have investigated the immediate and short-term impact of Ebola—but little is known about its long-term toll on those lucky enough to ...
| |||||
Custom Essays For Schools – Helping You Move Out Custom Essays For Schools – Helping You Move Out. Customized essays for colleges are a wonderful way to make yourself stick out from the crowd.
| |||||
BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National ... REGN-EB3 is Regeneron's investigational triple antibody cocktail treatment for Ebola virus infection and is currently under Priority Review by the U.S. ...
| |||||
BARDA Procures Regeneron's Investigational Ebola Treatment ... Authority (BARDA) has issued a multi-year contract to Regeneron for a supply of the company's investigational Ebola treatment REGN-EB3.
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar